[pending] ISOTRETINOIN (ISOTRETINOIN)
Pending LLM rewrite. Source: FDA_DRUG D-0446-2026.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: Pending LLM scoring against the rubric.
Plain-English summary
Superpotent and Subpotent
The recalled product
- Product
- ISOTRETINOIN (ISOTRETINOIN)
- Brand
- ISOTRETINOIN
- Manufacturer
- Teva Pharmaceuticals USA, Inc
- Category
- Drug — Drugs
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- Lots 100075305 Exp date 06/2027
- 100075512
- Exp date 07/2027 & 100076103
- Exp date 07/2027 .
Distribution
Distributed in 4 states:
- FL
- MS
- OH
- PR
Related recalls
Same brand · ISOTRETINOIN
- HighPrescription Drug Isotretinoin Recalled Due to Over-Potent Formulation
FDA (Drugs) · 2024-04-17
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- SevereErythromycin Tablets Recalled for Impurity Above Acceptable Limits
FDA (Drugs) · 2026-05-27
- ModeratePrimidone Tablets Recalled Due to API Cross-Contamination
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27